Diluent or Immuno-Reagent solutions for your diagnostic testing kits (Covid, Flu, etc.)
PR88639
PARIS, 23 March 2021 /PRNewswire=KYODO JBN/ --
Unither Pharmaceuticals, the Blow-Fill-Seal (BFS) worldwide leader,
provides diagnostic companies with capacity solutions and innovative
technologies for their testing kits (Covid, Flu, etc.).
With more than 10 million unit-doses manufactured each month for Covid
testing kits, the French CDMO answers to current challenges based on its
sterile unit doses development and manufacturing expertise.
The use of Blow-Fill-Seal technology, enables RNase-free single doses, that
can also be sterile if necessary.
Through its 5 BFS plants on three continents (in France, the United States
and China) and a R&D development center, Unither is able to manage the full
development of a diluent or reagent from formulation to production.
About Unither Pharmaceuticals
Founded in Amiens, France, in 1993, Unither Pharmaceuticals has become a
worldwide leader in drug manufacturing for generic pharmaceutical companies
including but not limited to, eye drops and respiratory unit doses, saline
solutions, and stick-packs.
Unither Pharmaceuticals has 7 manufacturing sites and 1 R&D center located
in France, the United States, China and Brazil. These sites generated a revenue
of €330 million in 2020 with a headcount exceeding 1.600 employees.
Website : www.unither-pharma.com
Blow-Fill-Seal :
https://www.unither-pharma.com/technologies-innovations/blow-fill-seal-bfs/?lang=en
Article :
Contact: testing@unither-pharma.com
Photo:
https://mma.prnewswire.com/media/1471718/Diluent_or_Immuno_Reagent_solutions.jpg
Logo:
https://mma.prnewswire.com/media/1471719/Unither_Pharmaceuticals_Logo.jpg
Source: Unither Pharmaceuticals
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。